XML 21 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Nov. 30, 2015
Nov. 30, 2014
Cash Flows From Operating Activities:    
Net income $ 184,511 $ 178,695
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Depreciation 33,509 30,132
Amortization 22,144 16,015
Reversal of contingent consideration obligations (14,500) (18,080)
Deferred income taxes (680) 2,170
Stock-based compensation expense 15,524 15,706
Other non-cash interest expense 4,862 1,329
Other 1,441 (2,551)
Changes in assets and liabilities, net of effect from purchases and sales of businesses:    
Decrease in receivables 117,358 44,564
(Increase) in inventory (49,781) (41,392)
Decrease in prepaid expenses and other current and long-term assets 4,617 1,306
(Decrease) in accounts payable (105,841) (133,960)
(Decrease) in accrued compensation and benefits (45,649) (57,837)
Increase (decrease) in accrued losses 715 (8,471)
Increase in other accrued liabilities 7,375 37,229
Other (8,532) (9,599)
Cash Provided By Operating Activities 167,073 55,256
Cash Flows From Investing Activities:    
Capital expenditures (31,295) (26,498)
Acquisition of businesses, net of cash acquired (12,006) (33,355)
Purchase of marketable securities (14,213) (14,308)
Proceeds from sales of marketable securities 11,737 19,205
Other 5,355 6,515
Cash (Used For) Investing Activities (40,422) (48,441)
Cash Flows From Financing Activities:    
Additions to long-term and short-term debt 38,765 83,312
Reductions of long-term and short-term debt (18,774) (6,501)
Cash dividends (71,276) (66,763)
Shares repurchased and returned for taxes (45,292) (8,954)
Payments of acquisition-related contingent consideration (1,631) (24,750)
Other 270 1,048
Cash (Used For) Financing Activities (97,938) (22,608)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (12,815) (20,548)
Net Change in Cash and Cash Equivalents 15,898 (36,341)
Cash and Cash Equivalents at Beginning of Period 174,711 332,868
Cash and Cash Equivalents at End of Period $ 190,609 $ 296,527